Cara Therapeutics | CARA - Assets

Stock Price
3.99
Daily Change
-0.03 -0.75%
Monthly
7.26%
Yearly
-72.52%
Q1 Forecast
3.87

Cara Therapeutics reported $43.75M in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Acadia Pharmaceuticals USD 1.56B 233.42M Dec/2025
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Assertio Holdings USD 319.77M 46M Sep/2025
Cara Therapeutics USD 43.75M 4.8M Jun/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Chugai Pharma JPY 2.47T 285.01B Dec/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
CSL USD 37.9B 1.5B Dec/2025
Grifols EUR 23.29B 3.35M Sep/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Neurocrine Biosciences USD 4.63B 365.8M Dec/2025
Pacira USD 1.26B 32.66M Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
RedHill Biopharma USD 18.38M 332K Jun/2025
Supernus Pharmaceuticals USD 1.45B 32.89M Dec/2025
Vanda Pharmaceuticals USD 488.95M 112.19M Dec/2025